Roundhill Glp-1 & Weight Loss ETF OZEM
30.89 USD +0.27 (+0.87%)
At closeNov 6, 2026, 4:00 PM EST
30.82 -0.07 -0.22%
After hours · Nov 6, 4:00 PM ET
30.36 Day range 30.95
28.34 52-week range 37.15
- YTD
- -9.58%
- 1 year
- +4.45%
- Market cap
- 39.39M
- EPS (ttm)
- 1.60
- P/E ratio
- 19.27
- YTD return
- -9.58%
- 1-year return
- +4.45%
- Volume
- 3.47K
- Avg volume
- 13.97K
- Open
- 30.36
- Previous close
- 30.62
- Day's range
- 30.36 – 30.95
- 52-week range
- 28.34 – 37.15
ALL +5.93 (+23.76%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 26.99
- 200-day average
- 27.14
About Roundhill Glp-1 & Weight Loss ETF
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
News
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most 
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval 
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk 
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain 
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' 
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential 
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk 
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Roundhill Investments Launches GLP-1 & Weight Loss ETF
Your note
Sign in to keep a note on OZEM — it syncs with the Stock Master app.